Fei Hou
Impact in
- Hepatology top 10%
- Liver physiology and pathology
- Ophthalmology top 10%
- Glaucoma and retinal disorders
Papers in
-
- RNA modifications and cancer 3
-
- Liver physiology and pathology 6
- Co-authors
- Juan Lv (4 shared papers)Xiaoya Liu (6 shared papers)Ruixia Liu (7 shared papers)Fukun Chen (5 shared papers)Zhiping Feng (3 shared papers)Pengjie Liu (3 shared papers)Cheng Chi (4 shared papers)Yan Wen (4 shared papers)
- Journals
- International Journal of Molecular Medicine (2 papers)eLife (2 papers)Frontiers in Bioscience-Landmark (1 paper)Developmental Neuroscience (1 paper)Molecular Carcinogenesis (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Fei Hou
38 papers receiving 701 citations
Peers
Comparison fields: 5 of 90
- Hepatology 64
- Ophthalmology 41
- Cell Biology 81
- Immunology 85
- Cancer Research 54
Countries citing papers authored by Fei Hou
This map shows the geographic impact of Fei Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Hou more than expected).
Fields of papers citing papers by Fei Hou
This network shows the impact of papers produced by Fei Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Hou. The network helps show where Fei Hou may publish in the future.
Co-authors
The 25 scholars most cited alongside Fei Hou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 90 | |
| 2 | 2016 | 72 | |
| 3 | 2021 | 59 | |
| 4 | 2020 | 49 | |
| 5 | 2017 | 43 | |
| 6 | 2020 | 42 | |
| 7 | 2023 | 35 | |
| 8 | Dexamethasone disrupts intercellular junction formation and cytoskeleton organization in human trabecular meshwork cells. | 2010 | 32 |
| 9 | Pro370Leu mutant myocilin disturbs the endoplasm reticulum stress response and mitochondrial membrane potential in human trabecular meshwork cells. | 2007 | 32 |
| 10 | 2016 | 27 | |
| 11 | 2017 | 27 | |
| 12 | 2024 | 25 | |
| 13 | 2023 | 23 | |
| 14 | 2017 | 17 | |
| 15 | 2015 | 14 | |
| 16 | 2018 | 13 | |
| 17 | 2016 | 13 | |
| 18 | 2015 | 13 | |
| 19 | 2016 | 10 | |
| 20 | 2022 | 8 |
About Fei Hou
Fei Hou is a scholar working on Molecular Biology, Hepatology, Epidemiology, Cancer Research and Oncology, having authored 44 papers that have together received 709 indexed citations. Recurring topics across this work include Liver physiology and pathology (6 papers), Chromosomal and Genetic Variations (4 papers), Ferroptosis and cancer prognosis (3 papers), RNA modifications and cancer (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Ginger and Zingiberaceae research (2 papers), Pancreatitis Pathology and Treatment (2 papers) and Autophagy in Disease and Therapy (2 papers). The work is most often cited by research in Hepatology (64 citations), Ophthalmology (41 citations), Cell Biology (81 citations), Immunology (85 citations) and Cancer Research (54 citations). Fei Hou has collaborated with scholars based in China and United States. Frequent co-authors include Juan Lv, Xiaoya Liu, Ruixia Liu, Fukun Chen, Zhiping Feng, Pengjie Liu, Cheng Chi, Yan Wen, Zhixian Yang and Chenghong Yin. Their work appears in journals such as International Journal of Molecular Medicine, eLife, Frontiers in Bioscience-Landmark, Developmental Neuroscience and Molecular Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.